Patrizia Giannatempo (@giannatempopatr) 's Twitter Profile
Patrizia Giannatempo

@giannatempopatr

ID: 899670545209405440

calendar_today21-08-2017 16:32:27

1,1K Tweet

474 Followers

699 Following

Sarah Scagliarini, MD (@sscagliarini_) 's Twitter Profile Photo

#UroOncoJourney2025 🇮🇹 The multidisciplinary debate on #RCC is always heated 🔥 even more so if the best ( Camillo Porta,Ciro Franzese, Andrea Minervini) take the field, expertly arbitrated by Roberto Iacovelli. However, the goal can only be achieved together!! 🥅 UroFocus ANTURE - Associazione Nazionale Tumore del Rene

#UroOncoJourney2025  🇮🇹
The multidisciplinary debate on #RCC is always heated 🔥 even more so if the best ( <a href="/CPRT65/">Camillo Porta</a>,<a href="/CiroFranzese1/">Ciro Franzese</a>, Andrea Minervini) take the field, expertly arbitrated by <a href="/DrIacovelli/">Roberto Iacovelli</a>. However, the goal can only be achieved together!! 🥅 <a href="/urofocus/">UroFocus</a> <a href="/AntureIT/">ANTURE - Associazione Nazionale Tumore del Rene</a>
EORTC (@eortc) 's Twitter Profile Photo

#MCCRWorkshop Faculty & Fellows, class of 2025! Since 1999, this workshop has fostered innovation, collaboration, and groundbreaking research in clinical cancer. #EORTC ESMO - Eur. Oncology AACR

#MCCRWorkshop Faculty &amp; Fellows, class of 2025! Since 1999, this workshop has fostered innovation, collaboration, and groundbreaking research in clinical cancer. 

#EORTC <a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/AACR/">AACR</a>
Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

Great, unbiased, discussion with Jonathan Rosenberg MD Petros Grivas on ctDNA in #BladderCancer – promising, but not practice-changing yet. – ctDNA is prognostic, not yet predictive – Avoid overinterpreting current data – Use selectively in clinical “gray zones” – Enroll patients in

Giuseppe Banna (@gbanna74) 's Twitter Profile Photo

Last chance to register FREE for #IUCS25 in Portsmouth or online! Join leading experts in urology cancer on Sept 4-5 for cutting-edge science & networking. Submit your abstract by June 30 for poster & mini-oral! 🔗 Register & submit: urologycancersummit.org #Urology OncoAlert

Last chance to register FREE for #IUCS25 in Portsmouth or online! 
Join leading experts in urology cancer on Sept 4-5 for cutting-edge science &amp; networking.
Submit your abstract by June 30 for poster &amp; mini-oral!
🔗 Register &amp; submit: urologycancersummit.org
#Urology <a href="/OncoAlert/">OncoAlert</a>
Roberto Iacovelli (@driacovelli) 's Twitter Profile Photo

What a great experience was the last 2 days at the #UROonco25. Great presentations and debates around GU cancers and great honour to be among the speakers for #RCC session. See you in 2026! Thanks to European Association of Urology (EAU) EAU Edu Platform UROONCO Alessandro Volpe 🙏🏻. OncoAlert OncoDaily UroFocus Kidney Cancer

What a great experience was the last 2 days at the #UROonco25. Great presentations and debates around GU cancers and great honour to be among the speakers for #RCC session. See you in 2026! Thanks to <a href="/Uroweb/">European Association of Urology (EAU)</a> <a href="/EAU_Uroonco/">EAU Edu Platform UROONCO</a> <a href="/foxal72/">Alessandro Volpe</a> 🙏🏻. <a href="/OncoAlert/">OncoAlert</a> <a href="/oncodaily/">OncoDaily</a> <a href="/urofocus/">UroFocus</a> <a href="/KidneyCancer/">Kidney Cancer</a>
Tom Powles (@tompowles1) 's Twitter Profile Photo

With the final analysis of the last of the 1st line metastatic clear cell RCC trials combination trials it’s still fair to say ‘pick one and use it well’. #GUARDSymposium2025 Ipi/nivo is less good at getting initial control but has less long term toxicity. Brian Rini, MD OncoAlert

With the final analysis of the last of the 1st line metastatic clear cell RCC trials combination trials it’s still fair to say ‘pick one and use it well’. #GUARDSymposium2025 Ipi/nivo is less good at getting initial control but has less long term toxicity. <a href="/brian_rini/">Brian Rini, MD</a> <a href="/OncoAlert/">OncoAlert</a>
European Urology (@euplatinum) 's Twitter Profile Photo

🚨 NEW in #EuropeanUrology By Saum Ghodoussipour Roger Li Sarah P. Psutka MD MS Trinity J. Bivalacqua Joan Palou Redorta et al Can novel intravesical therapies change the game for non–muscle-invasive bladder cancer? This systematic review explores: ✅ BCG-based combos ✅ Gene & immune therapies ✅ Innovative drug

🚨 NEW in #EuropeanUrology By <a href="/saumyg/">Saum Ghodoussipour</a> <a href="/UrogerliMD/">Roger Li</a> <a href="/spsutkaMD/">Sarah P. Psutka MD MS</a> <a href="/tbivala1/">Trinity J. Bivalacqua</a> <a href="/joanfundi/">Joan Palou Redorta</a> et al 

Can novel intravesical therapies change the game for non–muscle-invasive bladder cancer?

This systematic review explores:
✅ BCG-based combos
✅ Gene &amp; immune therapies
✅ Innovative drug
Tumori Journal (@tumorij) 's Twitter Profile Photo

🌟 #MeetTheEditors Genitourinary Oncology Section of TJ, led by dr. Giuseppe Giuseppe Procopio , dr. Patrizia Patrizia Giannatempo and dr. Marcello Tucci, is focused on evaluation of articles on detection, diagnosis, prevention and treatment of genitourinary tumors, promoting studies

🌟 #MeetTheEditors Genitourinary Oncology Section of TJ, led by dr. Giuseppe <a href="/g_procopio_/">Giuseppe Procopio</a> , dr. Patrizia <a href="/giannatempopatr/">Patrizia Giannatempo</a> and dr. Marcello Tucci, is focused on evaluation of articles on detection, diagnosis, prevention and treatment of genitourinary tumors, promoting studies
Elena Castro (@ecastromarcos) 's Twitter Profile Photo

Our last paper in Annals of Oncology: BRCA and HRR muts have similar prevalence in low and high volume mHSPC, but greater impact in low volume😯. Doublets with ARPi or docetaxel result in comparable poor outcomes for BRCA pts annalsofoncology.org/article/S0923-…

Our last paper in <a href="/Annals_Oncology/">Annals of Oncology</a>: BRCA and HRR muts have similar prevalence in low and high volume mHSPC, but greater impact in low volume😯. Doublets with ARPi or docetaxel result in comparable poor outcomes for BRCA pts
annalsofoncology.org/article/S0923-…